Anxiolytics /

This volume highlights today's and tomorrow's anxiolytics, examining in details the strengths and weaknesses of different classes of proposed anxiolytics. Each chapter is written by an acknowledged international expert actively working in the field. Essentially intended for researchers in...

Full description

Bibliographic Details
Main Author: Briley, Mike
Corporate Author: SpringerLink (Online service)
Other Authors: Nutt, David
Format: eBook
Language:English
Published: Basel : Birkhäuser Basel : Imprint : Birkhäuser, 2000.
Series:Milestones in drug therapy.
Subjects:
Online Access:Connect to the full text of this electronic book

MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000Ma 4500
001 in00003552182
006 m o d
007 cr nn|||||||||
008 121227s2000 sz o 000 0 eng d
005 20260421171006.7
020 |a 9783034884709 (electronic bk.) 
020 |a 3034884702 (electronic bk.) 
035 |a (OCoLC)840290573 
040 |a I9W  |b eng  |e pn  |c I9W  |d OCLCO  |d OCLCQ  |d UV0  |d OCLCO  |d GW5XE  |d OCLCF  |d UtOrBLW 
049 |a TXAM 
050 4 |a R1 
082 0 4 |a 610  |2 23 
100 1 |a Briley, Mike. 
245 1 0 |a Anxiolytics /  |c edited by Mike Briley, David Nutt. 
264 1 |a Basel :  |b Birkhäuser Basel :  |b Imprint :  |b Birkhäuser,  |c 2000. 
300 |a 1 online resource (IX, 181 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Milestones in drug therapy 
520 |a This volume highlights today's and tomorrow's anxiolytics, examining in details the strengths and weaknesses of different classes of proposed anxiolytics. Each chapter is written by an acknowledged international expert actively working in the field. Essentially intended for researchers in academia and the pharmaceutical industry, the book is also of interest to psychiatrists and medical students interested in this specialty. In addition those in the pharmaceutical industry (strategic marketing, licencing, portfolio management ...) who need to be able to foresee future developments in the anxiolytic drug scene will find the insights obtained from this volume to be invaluable. By putting side by side today's and tomorrow's anxiolytics the text underlines the progress made (and sometimes the lack of it) in different areas. After reading this book, the reader should have a good "feeling" of where the anxiolytic field is going in the next few years. 
500 |a Electronic resource. 
650 0 |a Medicine. 
650 7 |a Medicine.  |2 fast  |0 (OCoLC)fst01014893 
655 7 |a Electronic books.  |2 local 
700 1 |a Nutt, David. 
710 2 |a SpringerLink (Online service) 
830 0 |a Milestones in drug therapy. 
856 4 0 |u http://proxy.library.tamu.edu/login?url=https://link.springer.com/10.1007/978-3-0348-8470-9  |z Connect to the full text of this electronic book  |t 0 
994 |a 92  |b TXA 
999 |a MARS 
999 f f |s e79f2694-b6b9-35e9-9c51-ace9e83fb679  |i 6a1cdff9-223f-354c-be5c-32db5e8118e2  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |s www_evans  |d Available Online  |t 0  |e R1  |h Library of Congress classification 
998 f f |a R1  |t 0  |l Available Online